Gilead and Lakefront complete $1.675 billion Ouro Medicines acquisition

June 4, 2026 4:15 PM

Gilead Sciences (NASDAQ: GILD) and Lakefront Biotherapeutics (Euronext & NASDAQ: LKFT) completed their acquisition of Ouro Medicines for $1.675 billion ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found